DODGE & COXDODGE & COX

Institutional investor · Portfolio as of Q4 2025

Top Holdings222 positions

Checking export access…
Activity:

CHARLES SCHWAB CORP (THE)

76.5M$7.6B4.1%$43.19+129.07%
29 qtrssince 2018-Q4
Decreased
0

JOHNSON CONTROLS INTERNATION

60.4M$7.2B3.9%$36.44+225.81%
29 qtrssince 2018-Q4
Decreased
0

RTX CORPORATION

37.6M$6.9B3.7%$62.48+190.37%
23 qtrssince 2020-Q2
Decreased
0

CVS HEALTH CORP

62.5M$5B2.7%$57.68+34.45%
29 qtrssince 2018-Q4
Decreased
0

FEDEX CORP

15.6M$4.5B2.4%$142.98+60.90%
29 qtrssince 2018-Q4
Decreased
0

METLIFE INC

52.3M$4.1B2.2%$32.94+134.67%
29 qtrssince 2018-Q4
Decreased
0

ALPHABET INC

12.9M$4B2.2%$54.91+470.32%
29 qtrssince 2018-Q4
Decreased
0

BOOKING HOLDINGS INC

732,081$3.9B2.1%$78.27+171.73%
29 qtrssince 2018-Q4
Increased
59

MICROSOFT CORP

7.4M$3.6B1.9%$125.17+283.93%
29 qtrssince 2018-Q4
Decreased
0

REGENERON PHARMACEUTICALS

4.6M$3.5B1.9%$615.83+24.85%
17 qtrssince 2021-Q4
Increased
51

AMAZON COM INC

15.2M$3.5B1.9%$102.67+124.82%
29 qtrssince 2018-Q4
Decreased
0

ALPHABET INC

10.8M$3.4B1.8%$92.83+236.52%
29 qtrssince 2018-Q4
Decreased
0

TE CONNECTIVITY PLC

14.9M$3.4B1.8%$148.06+52.01%
6 qtrssince 2024-Q3
Decreased
0

COMCAST CORP NEW

113M$3.4B1.8%$28.36-6.25%
29 qtrssince 2018-Q4
Increased
50
GSKGSK
ADR

GSK PLC

68.5M$3.4B1.8%$27.45+74.02%
14 qtrssince 2022-Q3
Decreased
0

FISERV INC

49.5M$3.3B1.8%$103.84-35.31%
21 qtrssince 2020-Q4
Increased
63

META PLATFORMS INC

5M$3.3B1.8%$392.84+67.60%
23 qtrssince 2020-Q2
Increased
62

OCCIDENTAL PETE CORP

79.5M$3.3B1.8%$37.00+9.60%
29 qtrssince 2018-Q4
Decreased
0

FIDELITY NATL INFORMATION SV

49.1M$3.3B1.8%$63.21+1.88%
15 qtrssince 2022-Q2
Increased
57

GILEAD SCIENCES INC

26.3M$3.2B1.7%$52.66+128.98%
29 qtrssince 2018-Q4
Decreased
0
$185.3B
AUM
222
Positions
Q4 2025
Filing
HI score · 3.0/5
Quarterly 13F Value Change
+6%Q3'24$176.8B-3%Q4'24$171.8B+2%Q1'25$175.5B+1%Q2'25$178B+4%Q3'25$185.3B-0%Q4'25$185.3B
Activity profile
$ moved · Q4'25
New12%Increased36%Decreased50%Exited2%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.9 years
<1Q4%1-4Q8%1-2Y9%2Y+79%

DODGE & COX manages $185.3B across 222 positions as of Q4 2025. Top holdings: SCHW (4.1%), JCI (3.9%), RTX (3.7%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.

Q4 2025 Summary

Active quarter - 10 new positions, 7 exits, 39 increased. Top move: FISV (INCREASED, conviction 63). Portfolio: $185.3B across 222 positions.

Top holdings by portfolio weight

Total AUM$185B
SCHW4.13%
JCI3.90%
RTX3.72%
CVS2.68%
FDX2.43%
MET2.23%
GOOG2.18%
BKNG2.12%
MSFT1.94%
REGN1.92%
Other1.90%

Portfolio allocation by GICS sector

Sectors11
Healthcare23.70%
Financial Services19.44%
Industrials13.02%
Communication Services11.33%
Technology9.53%
Consumer Cyclical6.60%
Basic Materials4.30%
Energy4.29%
Real Estate2.55%
Consumer Defensive2.17%
Other3.08%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Healthcare, Financial Services, Industrials
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L75
Conviction37
Concentration42
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
CMCSACMCSACOMCAST CORP NEW
Q4 2024 → Q2 2026+41.8M shares-$248.2M
7Q
CPNGCPNGCOUPANG INC
Q4 2024 → Q2 2026+52.1M shares+$760.4M
7Q
LPLALPLALPL FINL HLDGS INC
Q4 2024 → Q2 2026+4.6M shares+$1.3B
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used